Den här hemsidan kräver JavaScript för att fungera tillfredsställande. Vänligen ändra dina inställningar eller använd en annan webläsare för att fortsätta.       

Du är nu på väg att lämna en GSK-hemsida

Denna länk leder till en hemsida som inte tillhör GSK. GSK tar inget ansvar för innehållet på tredje parts hemsidor.

Fortsätt

Tillbaka

Unit for Hours:H

Unit for Minutes: M

Filter redirection page URL: /content/cf-pharma/health-hcpportal/se_SE/hcp/home/events.html

Login overlay needed?:

Filter Tags:Terapiområde

Filter Tags values when filtered by all Tags:Alla terapiområden

OutofBox filter category name:Typ

Filter Reset all button text:Återställ

Filter Apply button text:Apply

Events registration success message: Registration successfull

Events registration failure message: Registration failure

Events un-registration success message: Un-Registration successfull

Events un-registration failure message: Un-Registration failure

Reset all default value: false

Tag Requirements value: all

Show More Naivagation Values: 10|25|50

Previous Text label: Tidigare

Next Text label: Nästa

Show Text label: Visa:

Seats left Text: Spaces left

No Seats left Text: No spaces left

Text Area Blank copy in Email Template:Ej ifyllt

  

Month Names:Januari,Februari,Mars,April,Maj,Juni,Juli,Augusti,September,Oktober,November,December

  

Month Names Short:Jan,Feb,Mar,Apr,Maj,Jun,Jul,Aug,Sep,Okt,Nov,Dec

  

Day Names:Söndag,Måndag,Tisdag,Onsdag,Torsdag,Fredag,Lördag

  

Day Names Short:Sön,Mån,Tis,Ons,Tor,Fre,Lör

  

Day Names Min:Sö,Må,Ti,On,To,Fr,Lö

  

Date Format:dag/månad/år

  • ASYEVE0001=Event Registration-Portal
  • ASYEVE0002=Watched General Video
  • ASYEVE0003=Watched Virtual Rep Video
  • ASYEVE0004=Watched Patient Video
  • ASYEVE0005=Watched Expert Video
  • ASYEVE0006=Watched Webcast
  • ASYEVE0007=Downloaded Content-Portal
  • ASYEVE0008=Clicked to App Store
  • ASYEVE0009=Watched Learning Module Video
  • ASYEVE0010=eMail Sent
  • ASYEVE0011=eMail Read
  • ASYEVE0012=eMail Clicked
  • ASYEVE0013=Shared a Link
  • ASYEVE0014=Rep Request
  • ASYEVE0015=Joined health.gsk
  • ASYEVE0016=email Not Sent
  • ASYEVE0017=Email Not Sent
  • ASYEVE0018=Email Not Sent
  • ASYEVE0037=IJSFAID is not available
  • ASYEVE0038=EMAIL ID and IJSFAID is not available
  • ASYEVE0039=The user is opted out
  • ASYEVE0040=Scope IDs are different
338 {0} - {1} of {2} items

CROI 2018—DTG versus LPV/r in second line (DAWNING): outcomes by WHO-recommended NRTI backbone

02-03-2018
Effectiveness of dolutegravir-based ART vs WHO-recommended lopinavir/ritonavir-based ART as second-line treatment in the DAWNING study

CROI 2018—DTG or EFV in HIV/TB Co-infected Adults

01-03-2018
Effectiveness of dolutegravir or efavirenz in combination with 2 NRTIs in HIV/TB co-infected adults receiving rifampin-based TB therapy

Glossary

Video: Identifying and phenotyping the patient with severe asthma

Video: Identifying and phenotyping the patient with severe asthma

Severe asthma treatment options

Goal setting for optimal asthma control

Diagnosis, severity and control

Interpreting guidelines

Identifying severe asthma patients in primary care

Identifying severe asthma patients

Living with asthma

Severe asthma morbidity and mortality

For Healthcare professionals. Inside Severe Asthma – educational information on asthma impact, asthma pathalogy and development, cost and community burden

How is severe asthma different from milder forms of asthma?

Asthma pathology and development

Asthma cost and community burden

Visa fler

Inga resultat. Försök med detta:

  •  Kontrollera stavningen på ditt sökord
  •  Försök igen med ett annat sökord
  •  Återställ eller ändra din filtrering (om du använde filter vid denna sökning)